FINOX Biotech was founded 2007 in Switzerland and has since been working on implementing its vision to offer high-quality, cost-effective and patient-friendly fertility products. They are specialised in developing fertility drugs and innovative, patient-friendly delivery devices.
Finox is unique in being the only biotech company to be focused only on fertility products – and as such all their expertise is directed to developing cost-effective and easy-to-use medication. Finox intends to build a complete portfolio for reproductive medicine and to become the pharmaceutical partner of choice in fertility treatments.
16.07.2018
Assets von Fertility Biotech erfolgreich verkauft (startupticker.ch)
30.06.2016
Gedeon Richter steigt bei Finox ein (startupticker.ch)
06.04.2016
BV Holding investiert 2.3 Millionen Franken in Finox (startupticker.ch)
29.05.2015
Finox: CHF12 million for further growth (startupticker.ch)
18.09.2014
Finox Biotech Shareholders Agree on 20MCHF Capital Raise (startupticker.ch)
No milestones
No Jobs
No videos and documents
No Awards
Website:
finoxbiotech.com/
Headquarter:
Kirchberg
Foundation Date:
September 2007
Sectors: